YOLFTbeta
Shinpoong Pharmaceutical Co Ltd

Shinpoong Pharmaceutical Co Ltd

019175 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

12,930.00KRW-170.00 (-1.30%)

Price History

Full chart

Market Stats

Previous Close13,100.00
Open12,860.00
Day Range12,860.00 – 13,110.00
52-Week Range7,570.00 – 28,500.00
Volume430
Market Cap716.16B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.16
50-Day Avg13,516.60
200-Day Avg16,743.75

About

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jei-Man Ryu
  • Employees809
  • Headquarters161, Yeoksam-ro, Seoul, South Korea, 06246, Korea
  • Websitehttps://shinpoong.co.kr

Leadership

  • Mr. Jei-Man RyuCEO & Inside Director · b. 1956
  • InIl JeongHead of Financial Management Division
  • Mr. JooYoung SungMD & Inside Director · b. 1965

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue220.29B195.95B194.15B185.00B187.39B189.72B197.75B189.24B209.29B200.23B221.09B234.68B
Growth (%)--11.05%-0.92%-4.71%+1.29%+1.24%+4.23%-4.31%+10.60%-4.33%+10.42%+6.15%
Cost of Revenue119.48B109.36B106.22B104.88B111.50B113.54B121.22B111.85B131.31B119.95B139.29B132.01B
Gross Profit100.81B86.59B87.93B80.12B75.89B76.18B76.53B77.39B77.97B80.28B81.80B102.67B
Gross Margin45.76%44.19%45.29%43.31%40.50%40.16%38.70%40.89%37.26%40.09%37.00%43.75%
Operating Expense81.56B82.35B78.36B72.31B68.13B70.58B68.68B91.69B0127.67B98.83B88.42B
Operating Income19.25B4.24B9.57B7.81B7.75B5.60B7.85B-14.31B77.97B-47.39B-17.03B14.26B
Operating Margin8.74%2.16%4.93%4.22%4.14%2.95%3.97%-7.56%37.26%-23.67%-7.70%6.07%
EBITDA---16.02B20.83B23.55B23.49B3.89B-21.92B-39.81B-27.14M22.53B
EBITDA Margin---8.66%11.12%12.41%11.88%2.06%-10.47%-19.88%-0.01%9.60%
Net Income3.35B1.48B-18.59B904.89M2.80B5.32B5.00B-11.58B-35.38B-57.33B-15.39B8.83B
Net Income Margin1.52%0.75%-9.58%0.49%1.50%2.81%2.53%-6.12%-16.90%-28.63%-6.96%3.76%
R&D5.75B9.14B6.39B4.63B4.87B5.97B5.62B17.33B30.38B42.28B17.88B10.44B
R&D as % of Total Revenue2.61%4.66%3.29%2.50%2.60%3.14%2.84%9.16%14.52%21.11%8.09%4.45%
Interest Expense00004.28B4.11B2.94B202.06M61.42M1.72B2.63B2.69B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%2.28%2.17%1.49%0.11%0.03%0.86%1.19%1.15%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets409.30B410.73B416.49B385.61B380.95B380.11B487.15B392.58B361.54B350.08B342.09B352.47B
Total Liabilities217.78B215.87B199.64B175.50B173.47B170.99B112.82B38.03B30.78B79.30B84.00B81.74B
Total Equity190.11B193.46B216.55B209.81B206.47B208.18B373.37B353.49B329.61B269.59B256.82B269.97B
Cash5.97B12.67B16.09B19.42B37.17B23.37B55.80B27.64B41.69B43.80B41.99B47.43B
Net Debt---93.14B70.27B82.68B---1.20B11.32B7.53B

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-48.16M9.89B18.96B10.15B32.05B19.35B20.06B-71.03B-26.44B-24.81B-15.15B17.25B
Investing Cash Flow-13.20B-112.94M-21.16B2.04B-10.31B-30.66B-94.96B49.03B----
Financing Cash Flow9.32B-3.15B5.52B-8.50B-4.15B-2.49B108.65B-6.42B----
Capital Expenditure7.38B1.90B1.50B3.08B1.79B12.07B2.65B4.42B6.23B15.03B6.09B3.99B
Free Cash Flow---6.59B30.21B5.17B16.94B-76.64B-32.67B-39.84B-21.24B13.26B
Dividends Paid1.59B2.06B--5.16B5.16B5.16B5.16B----
FCF to OCF---64.94%94.26%26.72%84.45%107.91%123.56%160.59%140.18%76.87%
Dividend Paid to FCF----17.06%99.72%30.43%-6.73%----

Earnings

Report DateJun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 30, 2016Mar 1, 2017May 31, 2017Aug 30, 2017Nov 29, 2017Feb 28, 2018May 30, 2018Aug 14, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 13, 2019Nov 14, 2019Mar 27, 2020May 13, 2020Aug 18, 2020Nov 12, 2020Mar 3, 2021May 17, 2021Aug 17, 2021Nov 11, 2021May 17, 2022Aug 16, 2022Nov 14, 2022Mar 1, 2023May 15, 2023Aug 14, 2023Nov 15, 2023Mar 21, 2024May 16, 2024Aug 14, 2024Nov 12, 2024Mar 20, 2025May 14, 2025Aug 12, 2025Nov 12, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------
EPS Actual200.96165.7454.52183.1785.6737.0398.85120.47170.99-169.3053.6791.97-93.3695.66119.01-49.69-0.30-47.381.2174.744.1549.75-7.19-415.9025.9269.0958.12-128.3217.6035.8216.65-30.7818.6948.7516.6522.4434.2736.1420.049.3728.207.60-38.48-104.03-89.71-181.89-331.47-137.23-175.53-157.07-648.44-50.67-1.03-1.92-246.55-25.0563.78124.439.006.68-149.23
Surprise-------------------------------------------------------------
Timing--------------------------------------------------After-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-marketPre-market---

Key Statistics & Ratios

Market Cap716.16B
Enterprise Value487.95B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.00
Price / Book2.69
Revenue (TTM)239.07B
Gross Profit (TTM)102.10B
EBITDA14.01B
Profit Margin-0.34%
Operating Margin-12.57%
Return on Equity-0.28%
Return on Assets0.48%
Shares Outstanding1.99M
Shares Float34.78M
Beta1.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
115.00Dec 29, 2021
20201×
115.00Dec 29, 2020
20141×
62.50Dec 29, 2014
20131×
52.88Dec 27, 2013
20121×
66.67Dec 27, 2012
20111×
66.67Dec 28, 2011
20101×
62.24Dec 29, 2010
20091×
62.24Dec 29, 2009
20081×
53.94Dec 29, 2008
20071×
48.82Dec 27, 2007
20061×
49.79Dec 27, 2006
20051×
41.49Dec 28, 2005
20041×
30.04Dec 29, 2004
20031×
48.82Dec 29, 2003
20021×
48.82Dec 27, 2002
19971×
37.55Jan 3, 1997
19961×
37.55Jan 3, 1996

Stock Splits

  • Dec 29, 20141.04:1
  • Dec 27, 20131.04:1
  • Dec 27, 20121.04:1
  • Dec 28, 20111.04:1
  • Apr 18, 201110:1
  • Dec 29, 20101.03:1